Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Arhaus Announces Evolution of Trade Program to Deepen Engagement with Interior Design Community

April 1, 2026

Lingerie Fighting Championships Announce Queen of the Cage — The Search for the Next LFC Star

April 1, 2026

April Fools’ Day 2026: the best and cringiest pranks

April 1, 2026

WISKII Partners With Pilates & Paws in Miami to Support Community Wellness and Animal Welfare

April 1, 2026

Noom Acquires Licensed 503A Pharmacy, Accelerating the Next Era of Preventive Care and Enabling Noom’s Expansion Beyond Weight Health

April 1, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » SENO Closes 700k Pre Seed Fundraising Round to Advance Its Next Generation Film Delivery Technology
Press Release

SENO Closes 700k Pre Seed Fundraising Round to Advance Its Next Generation Film Delivery Technology

By News RoomNovember 28, 20256 Mins Read
SENO Closes 700k Pre Seed Fundraising Round to Advance Its Next Generation Film Delivery Technology
Share
Facebook Twitter LinkedIn Pinterest Email

SHENZHEN, China, Nov. 28, 2025 (GLOBE NEWSWIRE) — SENO secured 700k in pre seed funding to accelerate research, testing, and platform development for its film based delivery technology while preparing for future technical evaluations in global markets.

Strategic Capital to Strengthen Research and Platform Development

SENO, an emerging technology company focused on the development of next generation ultra thin film delivery systems, announced the completion of its 700,000 USD pre seed fundraising round. The round places the company at a valuation of 7 million USD and marks a significant milestone as SENO moves into its next stage of platform development.

The new capital will support the company’s ongoing investment in materials science research, formulation work, and early stage platform validation. SENO plans to apply the funds to expand research and development infrastructure, conduct formulation and stability testing, enhance quality and safety systems, and prepare for future technical validation phases. A portion of the funding will also support pilot scale production planning and international readiness assessments.

The fundraising round represents the company’s first major external milestone as it continues to build a platform centered on dissolvable film technology. The funding will also enable the company to strengthen its internal scientific capabilities and broaden exploratory work on potential use cases across the global marketplace.

Building a Modular Platform for Future Adaptation

SENO is developing a modular film based delivery platform designed to support future use cases across a broad range of categories. Rather than limiting its research to any single product direction, the company is focused on engineering scalable ultra thin films that can later be adapted for multiple sectors.

Current research initiatives include advances in film forming materials, micro layer engineering for controlled release applications, packaging durability testing, early international compliance preparation, and human factor studies conducted in select overseas markets. These efforts support the company’s long term objective of creating a versatile platform with the potential to be applied to various consumer, wellness, and functional film related applications.

SENO’s science centered approach places emphasis on durability, consistency, and safety across all early stage evaluations. The company is positioning itself to serve as a materials driven innovator capable of supporting future product development paths as markets evolve.

International Pilot Programs and Global Strategy Alignment

As part of its pre commercialization groundwork, SENO has begun establishing small scale pilot programs in select international regions. These initiatives aim to assess supply chain readiness, study user behavior patterns, and refine quality assurance metrics in controlled environments.

The company is also working with international regulatory consultants to evaluate the evolving global framework for film based delivery technologies. These evaluations are intended to support long term compliance planning and ensure that future development steps align with standards that may apply across multiple jurisdictions.

A SENO spokesperson stated, “We are taking a compliance first and science driven approach. Every step we take now, whether in research, manufacturing, or overseas exploratory programs, is centered on creating a stable foundation for long term global expansion.”

Strengthening Technical Guidance and Cross Border Collaboration

SENO has continued to build its research advisory network by bringing in scientific advisors from materials engineering, biomaterial research, and formulation science fields. These advisors provide guidance on the company’s early stage development plans and platform scalability evaluation.

The company’s workforce spans the United States and Asia, reflecting SENO’s plan to maintain an internationally collaborative structure. This cross border model is intended to support technical problem solving across multiple domains, including materials science, global operations, regulatory navigation, and supply chain planning.

Jason Zhao, Co founder and United States Regional Director of SENO, shared, “I am proud to be part of a team that is focused on building technologies that may influence the way future routines operate. Supporting the early stages of this platform is a meaningful step for us.”

Focus on Long Term Infrastructure and Platform Stability

As SENO progresses through its early developmental checkpoints, the company is emphasizing the importance of system level readiness. The funding will support enhancements to laboratory infrastructure, quality management frameworks, and future testing environments.

To prepare for scalable development, the company is also evaluating processes for data collection, formulation consistency tracking, and cross regional material testing. These early infrastructure investments are intended to ensure that SENO can support larger technical validation phases and maintain reliable standards as the platform evolves.

SENO has stated that its approach prioritizes technical accuracy, safety, and global adaptability. The company intends to continue refining the core properties of its films while expanding its understanding of potential application scenarios that may emerge as the platform matures.

Research Driven Path Toward Market Readiness

SENO

The capital raised will allow SENO to continue progressing along its multi stage research roadmap. The company is preparing for advanced formulation work, further material durability testing, international compliance assessment, and broader performance studies. These steps represent essential components in the company’s long term platform development process.

SENO’s leadership views the fundraising round as foundational to its next phase of technical execution. The company expects continued growth across its research teams, increased collaboration with scientific advisors, and ongoing evaluations of international pathways that may support future adaptation.

While the company is still at the pre commercialization stage, the strategic funding will allow SENO to continue its focus on scientific verification, platform durability, and readiness for potential future applications.

About SENO

SENO is a technology company specializing in dissolvable film engineering and advanced delivery systems. The company develops ultra thin film platforms designed for future adaptability across multiple sectors. With teams located across several countries, SENO focuses on building scalable and high quality film based technologies supported by materials science research, global compliance preparation, and cross border collaboration.

Media Contact

Jason Zhao
Co-Founder, SENO
Email: [email protected]
Website

Disclaimer:  This content is provided by SENO. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. This content is for informational purposes only and should not be considered financial, investment, or business advice. All investments carry inherent risks, including the potential loss of capital. Readers are strongly encouraged to conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. Neither the media platform nor the publisher shall be held responsible for any inaccuracies, misrepresentations, or financial losses resulting from the use or reliance on the information in this press release. Speculate only with funds you can afford to lose. In the event of any legal claims or concerns regarding this article, we accept no liability or responsibility. Globenewswire does not endorse any content on this page.

Legal Disclaimer: This media platform provides the content of this article on an “as-is” basis, without warranties or representations of any kind, express or implied. We assume no responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained herein. Any complaints, copyright issues, or inquiries regarding this article should be directed to the content provider listed above.

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/cbe5c9b2-420b-46a1-afda-13415c09c7a4

https://www.globenewswire.com/NewsRoom/AttachmentNg/a7d49686-4498-4898-ae16-da30e471194e

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Arhaus Announces Evolution of Trade Program to Deepen Engagement with Interior Design Community

Lingerie Fighting Championships Announce Queen of the Cage — The Search for the Next LFC Star

WISKII Partners With Pilates & Paws in Miami to Support Community Wellness and Animal Welfare

Noom Acquires Licensed 503A Pharmacy, Accelerating the Next Era of Preventive Care and Enabling Noom’s Expansion Beyond Weight Health

Texan by Nature Announces 2026 Conservation Wranglers

Bitfarms Officially Rebrands as Keel Infrastructure; Completes U.S. Redomiciliation

Distalmotion Seeks to Expand US Indications in Uro-Gynecology with Latest FDA Submission

Change in Orion Group Executive Team as of 8 April 2026 – Berkeley Vincent appointed Executive Vice President, Innovative Medicines

Cellcosmet Unveils Hydra-Soothing Mask: A Clinical Breakthrough for Sensitive Skin and Post-Procedure Recovery

Editors Picks

Lingerie Fighting Championships Announce Queen of the Cage — The Search for the Next LFC Star

April 1, 2026

April Fools’ Day 2026: the best and cringiest pranks

April 1, 2026

WISKII Partners With Pilates & Paws in Miami to Support Community Wellness and Animal Welfare

April 1, 2026

Noom Acquires Licensed 503A Pharmacy, Accelerating the Next Era of Preventive Care and Enabling Noom’s Expansion Beyond Weight Health

April 1, 2026

Latest News

Texan by Nature Announces 2026 Conservation Wranglers

April 1, 2026

Bitfarms Officially Rebrands as Keel Infrastructure; Completes U.S. Redomiciliation

April 1, 2026

Distalmotion Seeks to Expand US Indications in Uro-Gynecology with Latest FDA Submission

April 1, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version